| Literature DB >> 28121076 |
Yvonne Boergeling1, Stephan Ludwig1.
Abstract
Our antiviral arsenal to fight influenza viruses is limited and we need novel anti-flu drugs. Recently, cellular drug targets came into focus and omics analysis were instrumental to suggest candidate factors. In this issue of The FEBS Journal, Kainov and colleagues used transcriptome data to investigate virus-induced changes in tryptophan metabolism that may serve as immunomodulatory approach against viruses.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28121076 DOI: 10.1111/febs.13997
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542